Ongoing research is determining whether cannabinoid ligands may be effective agents in the treatment of, for example, pain and inflammation, neurodegenerative disorders such as multiple sclerosis and Parkinson???s disease, and the wasting and emesis associated with AIDS and cancer chemotherapy (13???15).